Lab Vision's Avatar

Lab Vision

@labvisionai.bsky.social

Build your AI expertise with our weekly newsletter of AI progress, news, and tools curated for Biotech and Pharma professionals. No hype. No nonsense. Visit www.LabVision.ai

55 Followers  |  294 Following  |  5 Posts  |  Joined: 07.03.2024  |  1.4064

Latest posts by labvisionai.bsky.social on Bluesky

Really excited about the strategy Nvidia is taking to provide pre-built microservices for #biopharma! As someone following #AI in #drugdiscovery, plug-and-play access to powerful models like this is a game changer. No more building the basics from scratch

#TechBio #nvidia

23.03.2024 19:34 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
β€˜A landmark moment’: scientists use AI to design antibodies from scratch Modified protein-design tool could make it easier to tackle challenging drug targets β€” but AI antibodies are still a long way from reaching the clinic. Modified protein-design tool could make it easie...

A great example of AI's potential, but key challenges remain like improving binding affinity and immunogenicity before clinical use. Still, I'm stoked to see the boundaries of what's possible with cutting-edge #biotech #AI
www.nature.com/articles/d41...

22.03.2024 19:29 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

It's such a fascinating time to be in biotech and research. A change in how we approach research is happening with more and more evidence that AI can be a significantly useful tool. Thanks for sharing, Eric.

12.03.2024 16:37 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

Check out our homepage to sign up for the newsletter. www.labvision.ai As a thank you for signing up you'll receive our guide titled Demystifying ChatGPT: 5 Tips (and 1 Secret) to Unlock ChatGPT's Potential.

Stay up-to-date on AI tends for the Biotech and Pharma space.

11.03.2024 19:08 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

Very exciting! Looking forward to seeing what comes of this.

11.03.2024 19:04 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

@labvisionai is following 20 prominent accounts